Medical Science Liaison, Oncology, Lung & GU Tumors (Northern California)

Medical Science Liaison, Oncology, Lung & GU Tumors

The primary role of the Medical Science Liaison (MSL) is to engage in meaningful peer-to-peer scientific dialogue with healthcare system leaders such as Regional Thought Leaders (RTLs), National Thought Leaders, and Healthcare Professional (HCPs) within a defined geography to translate science into patient care. MSLs will also engage the top HCPs in high-disease burden hospitals.

The MSL captures medical insights and acts as a clinical & scientific advisor to cross-functional partners. Ensures applicable interactions are aligned with enterprise and medical strategies and ultimately serve to ensure patients have access to BMS medicines through their efforts to ensure the medical community is fully apprised of their safe and effective use. Additionally, the MSL will work with medical community to address other pertinent scientific related questions not limited to approved assets and indications. MSL engagement with HCPs is focused on pre- and peri-launch activities or according to lifecycle needs of the brand.

The MSL will engage in educational dialogue with relevant HCPs and share relevant clinical evidence and information based on the physicians' needs and in accordance with the field medical plan. The MSL will also be responsible for serving on a scheduled, standing basis as "Medical on Call" - virtually engaging treating physicians in the community, facilitated by their commercial counterpart, TAS (Therapeutic Area Specialist), to answer unsolicited off-label and technically complex questions in real time. The Medical on Call capability and operating model will be implemented in 2024/5 on a market-by-market basis as the technology and operating model are ready.

This role is field-based, and it is anticipated that the employee will spend a majority of the time in the field interacting with external stakeholders, including investigators and clinical thought leaders, while also supporting internal stakeholders and continuing to maintain a high level of therapeutic expertise.

Key Responsibilities

• Develops trusted relationships with appropriate academic and community Thought Leaders (TLs) in Oncology through high-quality peer-to-peer scientific dialogue in both proactive and reactive settings. The MSL will use various channels for interactions (1:1, group presentations, virtual, etc.)
• Effectively collaborates and engages in scientific dialogue with TLs to gain insights on clinical landscape to ensure development of a medical plan that is both product/disease area focused and translates into effective launch
• Proactively engages in scientific and clinical conversation to ensure development of a medical plan that is both product/disease area focused and translates into effective launch and LCM activities.
• Engages with medical societies, PAGs (Patient Advocacy Groups) and guideline committee members as appropriate.
• Provides training for external speakers as needed.
• Strategically engages payers in the pre- and peri-launch phases (with fHEOR and Account Executives).
• Provides medical support to address unsolicited HCP questions in real-time, both in face-to-face interactions and through the Medical on Call virtual capability.
• Develops credible connections with key Thought Leaders (TLs) in oncology through high-quality peer-to-peer scientific dialogue.
• Appropriately document and achieve annual goals
• Leverages digital capabilities to enhance medical engagement

Clinical Trial Engagement

• Provides recommendations and insights to clinical development team on study feasibilities within the therapeutic area based on knowledge of the field and through direct contacts with potential investigators, as agreed with home office medical and GDO.
• Liaises with key large accounts to understand clinical barriers to patient access and ensuring equity in access to clinical trials.
• Leads major evidence read-outs with clinical trial investigators e.g., Ph 3 top-line data.
• Support Interventional and Non-Interventional Research (NIR) studies (e.g. identification and assessment of potential study sites) to facilitate patient recruitment and/or discussions around the safe and effective use of BMS investigational products, as agreed with home office medical and GDO and as defined by the study scope document
• Provide recommendations and insights to clinical development team on study and site feasibilities within the therapeutic area based on knowledge of the field and through direct contacts with potential investigators, as agreed with home office medical and GDO
• Support HCPs in the ISR submission and execution process and study follow-up as agreed upon with home office medical and GDO
• Ensure that BMS Pharmacovigilance procedural documents are understood and applied by investigators of local studies, and alert appropriate BMS personnel to any identified Adverse Events
• If applicable, support CRO sponsored studies as agreed with home office medical and GDO and as defined by the study scope document

Required Qualifications & Experience

• MD, PharmD, PhD, APP, PA, NP with experience in a specific Disease Area or with a broad medical background or relevant pharmaceutical experience
• Working in a scientific and/or clinical research environment. Field medical expertise preferred.
• Deep understanding of TL environment and needs.

Strong oncology experience required

• Scientific or clinical disease area knowledge, patient treatment trends, clinical landscape
• Pharmaceutical industry including compliance and regulatory guidelines

Understanding of scientific publications

• Clinical trial design and process
• Understanding of national and regional healthcare and access environment.

Travel

• As this position requires the operation of a Company-provided vehicle, offers of employment are contingent upon the candidate meeting the requirements of "Qualified Driver," as determined by the Company in its sole discretion, including but not limited to the following: 1) at least 21 years of age; 2) a driver's license in good standing issued by your state of residence; and, 3) a driving risk level deemed acceptable by the Company.
• The MSL will spend majority of their time in the field with their external customers and additional requirements based on territory assignment and team needs, as needed.

Key Competencies Desired

Scientific Agility

• Ability to engage in a dialogue about data in a compelling, fair and balanced way and explain in a manner that resonates with TLs/HCPs
• Expert knowledge of clinical practice and evolving healthcare delivery models.
• Ability to understand and critically appraise scientific publications.
• Knowledge of clinical trial design and methodology, including Good Clinical Practices and ethical, governmental, and regulatory requirements.
• Understands treatment paradigms, competitive landscape and can frame information in a convincing and compliant way that resonates with physicians.
• Excellent communication and presentation skills to articulate scientific and clinical data in an easy-to-understand manner to help HCPs best serve their patients.
• Has a strong learning mindset and passion for science. Prioritizes staying current with the latest data.

Patient centricity

• Understands the patient journey and experience.
• Has a patient-focused mindset.

Customer-focused/enterprise mindset

• Understands overall enterprise objectives and prioritization.
• Winning Mindset: results-oriented, positive, resilient attitude, able to quickly adapt in an ever-changing environment.
• Willingness to embrace new ways of working and technological tools.
• Demonstrated ability to drive organizational performance.
• Experience identifying, engaging, and cultivating relationships with HCPs.
• Demonstrated ability to influence matrix organization and problem-solving mentality.

Analytical Capability

• Ability to analyze data, such as market trends, and HCP preferences. Data-driven insights help them strategize and target their efforts effectively.
• Ability to segment HCPs based on their preferences and other relevant factors. This helps them tailor their communication and proactive presentations to suit individual HCP needs.
• Ability to derive actionable insights from data and analytics, including CE^3 analytics engine.
• Providing feedback proactively to enable continuous improvement of technology and tools like CE^3.

Technological Agility

• Understanding, adapting, and effectively using technology in various aspects of healthcare business and interacting with HCPs.